Average cost of drugs for extensively drug-resistant tuberculosis in Syria
Syria: Average cost of drugs for extensively drug-resistant tuberculosis was 5,125 constant 2022 US$ in 2023. ▼ Falling
Latest (2023)
5,125 constant 2022 US$
Change on year
up 2.5%
World rank
10th
of 56 countries
All-time high
8,000 constant 2022 US$
in 2020
All-time low
5,000 constant 2022 US$
in 2021
Years of data
7
2017–2023
Average cost of drugs for extensively drug-resistant tuberculosis in Syria, 2017–2023
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
Syria recorded 5,125 constant 2022 US$ for average cost of drugs for extensively drug-resistant tuberculosis in 2023.
Compared with earlier readings it is up 2.5% on the previous year and down 14.6% over ten years.
Syria ranks 10th of 56 countries on this measure, in the top quarter.
Average cost of drugs for extensively drug-resistant tuberculosis in Syria, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 6,000 constant 2022 US$ | — |
| 2018 | 6,000 constant 2022 US$ | +0.0% |
| 2019 | 6,000 constant 2022 US$ | +0.0% |
| 2020 | 8,000 constant 2022 US$ | +33.3% |
| 2021 | 5,000 constant 2022 US$ | -37.5% |
| 2022 | 5,000 constant 2022 US$ | +0.0% |
| 2023 | 5,125 constant 2022 US$ | +2.5% |
Syria compared with similar countries
- Syria's 5,125 constant 2022 US$ is above the median for low income countries, which is 1,709 constant 2022 US$, 3.0× the median. (9 countries reporting)
- Syria's 5,125 constant 2022 US$ is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 2,000 constant 2022 US$, 2.6× the median. (7 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 6,000 constant 2022 US$ | 6,000 constant 2022 US$ | 6,000 constant 2022 US$ | 3 |
| 2020s | 5,781 constant 2022 US$ | 5,000 constant 2022 US$ | 8,000 constant 2022 US$ | 4 |
Countries ranked near Syria
More reference data data for Syria
- Emission Totals - Indirect emissions (N2O) - Agricultural Soils 7.23 (2050)
- Emission Totals - Indirect emissions (N2O) - IPCC Agriculture 7.23 (2050)
- Emission Totals - Indirect emissions (N2O) - Crop Residues 0.5377 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure left on Pasture 4.23 (2050)
- Emission Totals - Indirect emissions (N2O) - Manure applied to Soils 0.1191 (2050)
- Emission Totals - Emissions (N2O) - Agricultural Soils 29.01 (2050)
- Emission Totals - Direct emissions (N2O) - Manure left on Pasture 11.91 (2050)
- Emission Totals - Emissions (CO2eq) from N2O (AR5) - IPCC Agriculture 7,753 (2050)
- Emission Totals - Emissions (CO2eq) (AR5) - Crop Residues 775.73 (2050)
- Emission Totals - Direct emissions (N2O) - IPCC Agriculture 21.78 (2050)
Frequently asked questions
- What is average cost of drugs for extensively drug-resistant tuberculosis in Syria?
- Average cost of drugs for extensively drug-resistant tuberculosis in Syria was 5,125 constant 2022 US$ in 2023, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of drugs for extensively drug-resistant tuberculosis recorded in Syria?
- The highest recorded value was 8,000 constant 2022 US$ in 2020.
- What is the lowest average cost of drugs for extensively drug-resistant tuberculosis recorded in Syria?
- The lowest recorded value was 5,000 constant 2022 US$ in 2021.
- How does Syria rank for average cost of drugs for extensively drug-resistant tuberculosis?
- Syria ranks 10th out of 56 countries with data for 2023.
- Is average cost of drugs for extensively drug-resistant tuberculosis rising or falling in Syria?
- Over the last ten years it is down 14.6%. The long-run trend across the full record is falling.
- Where does this Syria data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of drugs for extensively drug-resistant tuberculosis. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 7 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting extensively drug-resistant tuberculosis treatment, excluding buffer stock.